Castle Biosciences, Inc. CSTL
$35.17
$1.735.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.96% | -12.63% | 4.16% | 4.21% | 0.28% |
| Total Receivables | 14.18% | -2.06% | -12.23% | -4.93% | -6.39% |
| Inventory | 1.14% | 2.02% | 18.54% | 3.39% | 22.15% |
| Prepaid Expenses | 5.94% | 92.40% | -35.90% | -3.31% | 6.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.71% | -8.92% | 0.99% | 2.55% | -0.21% |
|
|
|||||
| Total Current Assets | 3.71% | -8.92% | 0.99% | 2.55% | -0.21% |
| Net Property, Plant & Equipment | 3.05% | 2.78% | 12.20% | 11.69% | 34.51% |
| Long-term Investments | 0.01% | -0.01% | 0.01% | -0.01% | 0.00% |
| Goodwill | 0.01% | -0.01% | 0.01% | -0.01% | 0.00% |
| Total Other Intangibles | -2.60% | -2.50% | -2.50% | -2.43% | 39.01% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.55% | 9.78% | 69.48% | 40.41% | 4.72% |
| Total Assets | 2.44% | -5.32% | 2.80% | 3.31% | 8.57% |
|
|
|||||
| Total Accounts Payable | -35.71% | -19.63% | 53.23% | -7.36% | 55.03% |
| Total Accrued Expenses | 31.69% | -42.06% | 19.29% | 21.43% | 30.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 48.37% | 58.41% | 27.26% | -58.78% | 38.06% |
| Total Finance Division Other Current Liabilities | 73.32% | 54.43% | -21.33% | 25.54% | 24.88% |
| Total Other Current Liabilities | 73.32% | 54.43% | -21.33% | 25.54% | 24.88% |
| Total Current Liabilities | 15.89% | -29.00% | 24.17% | 8.68% | 36.53% |
|
|
|||||
| Total Current Liabilities | 15.89% | -29.00% | 24.17% | 8.68% | 36.53% |
| Long-Term Debt | -14.78% | -12.87% | -4.07% | 24.12% | -9.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.97% | -0.50% | -0.43% | -0.39% | 79.04% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -39.29% | -0.26% | -19.13% | 2.51% | 452.69% |
| Total Liabilities | 5.51% | -19.77% | 12.47% | 7.15% | 45.50% |
|
|
|||||
| Common Stock & APIC | 1.55% | 0.78% | 0.89% | 1.77% | 1.60% |
| Retained Earnings | -0.86% | -6.47% | -1.05% | -0.23% | 2.00% |
| Treasury Stock & Other | -306.35% | -123.60% | 11.25% | 515.38% | -70.23% |
| Total Common Equity | 1.87% | -2.01% | 0.82% | 2.56% | 3.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.87% | -2.01% | 0.82% | 2.56% | 3.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.87% | -2.01% | 0.82% | 2.56% | 3.42% |
|
|
|||||